MM

Mark Merchant

Revolution Medicines (United States) US

ORCID 0000-0003-0690-8581
380
Publications
10,417
Citations
48
H-Index
80
i10-Index
1.31
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Lung Cancer Treatments and Mutations (51) PI3K/AKT/mTOR signaling in cancer (43) Protein Degradation and Inhibitors (41) Liver physiology and pathology (38) Melanoma and MAPK Pathways (38)

Affiliations

Northwestern University
US 2004 - 1999
Oslo University Hospital
NO 2013 - 2013
Lawrence Livermore National Laboratory
US 1999 - 1999
Roche (United States)
US 2023 - 2023
Exelixis (United States)
US 2011 - 2011

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now